Curry spice component may help slow prostate tumor growth
Curcumin, an active component of the Indian curry spice turmeric, may help slow down tumor growth in castration-resistant prostate cancer patients on androgen deprivation therapy (ADT), a study from researchers ...
Cancer
Feb 10, 2012 |
4.5 / 5 (10) |
0
|
Finger ratio points to penile length
The ratio between the second and fourth digits is linked to stretched penile length according to a study published online this week in Asian Journal of Andrology. This finding suggests that digit ratio can predict adult ...
Other
Jul 05, 2011 |
3.8 / 5 (4) |
5
Capability of curry component to treat disease merits US patent
A U.S patent issued today to the University of Rochester and two other entities for the use of compounds related to a popular spice in the fight against cancer, acne, baldness, and other medical conditions.
Medical research
Jun 12, 2012 |
3.7 / 5 (3) |
2
Study identifies new prostate cancer drug target
Research led by Wanguo Liu, PhD, Associate Professor of Genetics at LSU Health Sciences Center New Orleans, has identified a new protein critical to the development and growth of prostate cancer. The findings are published ...
Cancer
Feb 06, 2012 |
5 / 5 (2) |
0
|
Scientists solve key piece of prostate cancer puzzle
Cancer Research UK scientists have revealed a completely new route by which male androgen hormones fuel the growth of prostate cancer, raising the prospect that existing drugs could be used to treat the disease.
Cancer
Aug 14, 2012 |
5 / 5 (2) |
0
|
Study sheds light on role of exercise and androgens such as testosterone on nerve damage repair
A study by researchers from Emory University and Indiana University found that the beneficial effects daily exercise can have on the regeneration of nerves also require androgens such as testosterone in both males and females. ...
Neuroscience
Oct 15, 2012 |
5 / 5 (2) |
0
Clinical trial hits new target in war on breast cancer
Breast cancers are defined by their drivers – estrogen and progesterone receptors (ER and PR) and HER2 are the most common, and there are drugs targeting each. When breast cancer has an unknown driver, it also has fewer ...
Cancer
Dec 03, 2012 |
5 / 5 (2) |
0
|
How some prostate tumors resist treatment—and how it might be fixed
Hormonal therapies can help control advanced prostate cancer for a time. However, for most men, at some point their prostate cancer eventually stops responding to further hormonal treatment. This stage of ...
Cancer
Mar 18, 2013 |
5 / 5 (2) |
0
|
Reducing the side effects of treatment for prostate cancer
New research published in BioMed Central's open access journal BMC Medicine reassessing clinical data from trials, which investigate ways of treating side effects of therapy for prostate cancer, finds that tamoxifen, an ant ...
Cancer
Aug 27, 2012 |
4.5 / 5 (2) |
0
New drug extends survival in patients with drug-resistant prostate cancer
A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular receptor that drives progression ...
Cancer
Feb 01, 2012 |
5 / 5 (1) |
0
|
Study role testosterone may play in triple negative breast cancer
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. ...
Cancer
Mar 23, 2012 |
5 / 5 (1) |
0
|
Early clinical data show galeterone safe, effective against prostate cancer
Patients with castration-resistant prostate cancer had limited side effects and in many cases a drop in prostate-specific antigen expression with galeterone (TOK-001), a small-molecule oral drug, according to phase I data ...
Cancer
Apr 01, 2012 |
5 / 5 (1) |
0
Low testosterone levels could raise diabetes risk for men
Low levels of testosterone in men could increase their risk of developing diabetes, a study suggests.
Medical research
May 04, 2012 |
5 / 5 (1) |
0
|
New target, new drug in breast cancer
Many breast cancers depend on hormones including estrogen or progesterone for their survival and proliferation. Eight years of lab work at the University of Colorado Cancer Center and elsewhere suggest that the androgen (AR) ...
Cancer
Jun 04, 2012 |
5 / 5 (1) |
0
Enzalutamide adds five months survival in late-stage prostate cancer
Results of a phase III clinical trial of the drug Enzalutamide, published yesterday in the New England Journal of Medicine, show the drug extends life by an average five months in the most advanced stages of prostate cancer ...
Cancer
Aug 16, 2012 |
5 / 5 (1) |
0
